Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Craig Michael Forester

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PEDS

    Collapse Biography 
    Collapse education and training
    University of Wisconsin, Madison, WIB.S.06/2000Medical Microbiology & Immunology
    University of Utah, Salt Lake City, UTM.D., Ph.D.06/2009Oncological Sciences
    Boston Combined Residency Program, Boston, MA06/2012Pediatrics
    UCSF; Benioff Children's Hospital, San Francisco, CA07/2015Pediatric Hematology/Oncology/BMT
    Collapse awards and honors
    2015 - 2016Career Development Program Grant, Leukemia & Lymphoma Society
    2016 - 2018Child Health Research Career Development Award (CHRCDA) Program K12 Award, NICHD
    2019ASH Scholar Award, American Society of Hematology

    Collapse Overview 
    Collapse overview
    Dr. Forester earned a B.S. in Medical Microbiology and Immunology at the University of Wisconsin in Madison followed by a combined M.D. and Ph.D in the lab of David Virshup (Oncological Sciences) at the University of Utah. He then completed internship and residency at the Boston Combined Residency in Pediatrics (BCRP) at Boston Children’s Hospital/Boston Medical Center. This was followed by fellowship in Pediatric Hematology/Oncology/BMT at the University of California – San Francisco with a post-doctoral fellowship in the lab of Davide Ruggero and moved into a junior faculty position with a clinical interest in hemoglobinopathies, bone marrow failure and HSCT. He was most recently recruited to the University of Colorado where his lab focuses on determinants of RNA sequence and structure guiding recognition of the translational machinery to define hematopoietic differentiation.

    Collapse Research 
    Collapse research activities and funding
    HRSA-18-079     (Vichinsky)Jun 1, 2018 - Aug 1, 2019
    HHS
    Cooperative Agreements to Support Comprehensive Medical Care for Thalassemia
    Role: Co Investigator

    K08DK119561     (FORESTER, CRAIG M.)Apr 1, 2019 - Feb 28, 2023
    NIH
    Profiling Translational Control of Gene Expression and Nascent Proteomic Responses in Erythropoietic Progression and Ribosomopathies
    Role: Principal Investigator

    A 132428     (Forester)Jul 1, 2019 - Jun 30, 2021
    American Society of Hematology
    Determinants of Translational Control in Early Erythropoiesis

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Tiu GC, Kerr CH, Forester CM, Krishnarao PS, Rosenblatt HD, Raj N, Lantz TC, Zhulyn O, Bowen ME, Shokat L, Attardi LD, Ruggero D, Barna M. A p53-dependent translational program directs tissue-selective phenotypes in a model of ribosomopathies. Dev Cell. 2021 Jul 03. PMID: 34242585.
      View in: PubMed
    2. Forester CM, Ruggero D. Releasing the brake on protein synthesis in hematopoietic stem cells. Cell Stem Cell. 2021 Jul 01; 28(7):1183-1185. PMID: 34214436.
      View in: PubMed
    3. McMahon M, Contreras A, Holm M, Uechi T, Forester CM, Pang X, Jackson C, Calvert ME, Chen B, Quigley DA, Luk JM, Kelley RK, Gordan JD, Gill RM, Blanchard SC, Ruggero D. A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS. Elife. 2019 09 03; 8. PMID: 31478838.
      View in: PubMed
    4. Balkin DM, Poranki M, Forester CM, Dorsey MJ, Slavotinek A, Pomerantz JH. TASP1 mutation in a female with craniofacial anomalies, anterior segment dysgenesis, congenital immunodeficiency and macrocytic anemia. Mol Genet Genomic Med. 2019 09; 7(9):e818. PMID: 31350873.
      View in: PubMed
    5. Xu Y, Poggio M, Jin HY, Shi Z, Forester CM, Wang Y, Stumpf CR, Xue L, Devericks E, So L, Nguyen HG, Griselin A, Gordan JD, Umetsu SE, Reich SH, Worland ST, Asthana S, Barna M, Webster KR, Cunningham JT, Ruggero D. Translation control of the immune checkpoint in cancer and its therapeutic targeting. Nat Med. 2019 02; 25(2):301-311. PMID: 30643286.
      View in: PubMed
    6. Lal A, Wong TE, Andrews J, Balasa VV, Chung JH, Forester CM, Ikeda AK, Keel SB, Pagano MB, Puthenveetil G, Shah SJ, Yu JC, Vichinsky EP. Transfusion practices and complications in thalassemia. Transfusion. 2018 12; 58(12):2826-2835. PMID: 30260477.
      View in: PubMed
    7. Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, Walter P, Carroll PR, Ruggero D. Development of a stress response therapy targeting aggressive prostate cancer. Sci Transl Med. 2018 05 02; 10(439). PMID: 29720449.
      View in: PubMed
    8. Terenzio M, Koley S, Samra N, Rishal I, Zhao Q, Sahoo PK, Urisman A, Marvaldi L, Oses-Prieto JA, Forester C, Gomes C, Kalinski AL, Di Pizio A, Doron-Mandel E, Perry RB, Koppel I, Twiss JL, Burlingame AL, Fainzilber M. Locally translated mTOR controls axonal local translation in nerve injury. Science. 2018 03 23; 359(6382):1416-1421. PMID: 29567716.
      View in: PubMed
    9. Forester CM, Zhao Q, Phillips NJ, Urisman A, Chalkley RJ, Oses-Prieto JA, Zhang L, Ruggero D, Burlingame AL. Revealing nascent proteomics in signaling pathways and cell differentiation. Proc Natl Acad Sci U S A. 2018 03 06; 115(10):2353-2358. PMID: 29467287.
      View in: PubMed
    10. Huang X, He Y, Dubuc AM, Hashizume R, Zhang W, Reimand J, Yang H, Wang TA, Stehbens SJ, Younger S, Barshow S, Zhu S, Cooper MK, Peacock J, Ramaswamy V, Garzia L, Wu X, Remke M, Forester CM, Kim CC, Weiss WA, James CD, Shuman MA, Bader GD, Mueller S, Taylor MD, Jan YN, Jan LY. EAG2 potassium channel with evolutionarily conserved function as a brain tumor target. Nat Neurosci. 2015 Sep; 18(9):1236-46. PMID: 26258683.
      View in: PubMed
    11. Forester CM, Sartain SE, Guo D, Harris MH, Weinberg OK, Fleming MD, London WB, Williams DA, Hofmann I. Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors. Am J Hematol. 2015 Apr; 90(4):320-6. PMID: 25580823.
      View in: PubMed
    12. Forester CM, Terry J, Lee EY, Simoneau T, Haver K. Skin lesions and lung cysts in a neonate. J Pediatr. 2012 Jun; 160(6):1061-1.e1. PMID: 22404953.
      View in: PubMed
    13. Niazi TN, Forester C, Afify Z, Riva-Cambrin J. Osteosarcoma presenting as hemorrhagic cerebellar metastasis. Childs Nerv Syst. 2009 Dec; 25(12):1643-7. PMID: 19763588.
      View in: PubMed
    14. Forester CM, Braunreiter CL, Yaish H, Hedlund GL, Afify Z. Tumefactive intracranial presentation of precursor B-cell acute lymphoblastic leukemia. Pediatr Radiol. 2009 Nov; 39(11):1230-3. PMID: 19763560.
      View in: PubMed
    15. Forester CM, Maddox J, Louis JV, Goris J, Virshup DM. Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1. Proc Natl Acad Sci U S A. 2007 Dec 11; 104(50):19867-72. PMID: 18056802.
      View in: PubMed
    16. Margolis SS, Perry JA, Forester CM, Nutt LK, Guo Y, Jardim MJ, Thomenius MJ, Freel CD, Darbandi R, Ahn JH, Arroyo JD, Wang XF, Shenolikar S, Nairn AC, Dunphy WG, Hahn WC, Virshup DM, Kornbluth S. Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell. 2006 Nov 17; 127(4):759-73. PMID: 17110335.
      View in: PubMed
    Forester's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)